已核实 DOI PubMed 相关产品: 50

Preparation and anti-tumor activity of selenium nanoparticles based on a polysaccharide from Paeonia lactiflora

Journal 2023 · IF 8.2 · 发表于 2023 年 1 月 14 日
作者: Xuelian Wang,Wenhui Liu,Yeling Li,Lingling Ma,Zhen Lin,Jing Xu,Yuanqiang Guo
阅读全文 在 PubMed 查看

摘要

The combination of selenium and polysaccharides is one of the significant ways to ameliorate the anti-cancer effects of polysaccharides. PLP50-1, a homogeneous polysaccharide purified from the aqueous extract of Paeonia lactiflora , had a molecular weight of 1.52 × 10 4  Da and consisted of α -D-Glc p -(1→, →4)- α -D-Glc p -(1→, →6)- α -D-Glc p -(1→, →4,6)- α -D-Glc p -(1→, and →6)- β -D-Fru f -(2→. PLP50-1 showed weak anti-tumor effects against A549 cells. To ameliorate the activity of PLP50-1, the complex nanoparticles combining P. lactiflora polysaccharide with selenium were constructed successfully. Structural properties of the polysaccharide-based selenium nanoparticles (PLP-SeNPs) were clarified using various means. The results displayed that a kind of monodisperse spherical nanoparticles containing high selenium content (39.1 %) with controllable size was constructed and showed satisfactory stability. The cellular anti-tumor assay indicated that PLP-SeNPs had stronger antiproliferative activity against A549 cells than PLP50-1. Additionally, the zebrafish experiments displayed that PLP-SeNPs inhibited the proliferation and migration of A549 cells significantly and blocked the angiogenesis.

本研究中使用的阿拉丁产品

50 款产品在本文中被引用